ZEALAND PHARMA A/S (22Z.DE) Stock Analyst Ratings
Europe - FRA:22Z - DK0060257814 - Common Stock
68.02 EUR
+4.88 (+7.73%)
ChartMill assigns a Buy % Consensus number of 85% to 22Z.DE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 107.77. This target is 58.44% above the current price.
22Z.DE was analyzed by 24 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about 22Z.DE.
In the previous month the buy percentage consensus was at a similar level.
22Z.DE was analyzed by 24 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
ZEALAND PHARMA A/S / 22Z.DE FAQ
What is the average price target for ZEALAND PHARMA A/S (22Z.DE) stock?
24 analysts have analysed 22Z.DE and the average price target is 107.77 EUR. This implies a price increase of 58.44% is expected in the next year compared to the current price of 68.02.
What is the consensus rating for ZEALAND PHARMA A/S (22Z.DE) stock?
The consensus rating for ZEALAND PHARMA A/S (22Z.DE) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover ZEALAND PHARMA A/S (22Z.DE) stock?
The number of analysts covering ZEALAND PHARMA A/S (22Z.DE) is 24.